Genistein treatment of cells inhibits arenavirus infection.
about
The regulatory role of activating transcription factor 2 in inflammationProgress in the experimental therapy of severe arenaviral infectionsProteomic analysis of Pichindé virus infection identifies differential expression of prothymosin-alpha.Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics.Comparative pathogenesis and systems biology for biodefense virus vaccine development.Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.Single nucleoprotein residue modulates arenavirus replication complex formation.Exploring kinase inhibitors as therapies for human arenavirus infections.Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entryCell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan.Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses.Highlights in antiviral drug research: antivirals at the horizon.Host cell factors as antiviral targets in arenavirus infection.Animal models, prophylaxis, and therapeutics for arenavirus infections.Meta-analysis of high-throughput datasets reveals cellular responses following hemorrhagic fever virus infection.Flavonoids: promising natural compounds against viral infections.Sodium hydrogen exchangers contribute to arenavirus cell entry.siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target.Apigenin inhibits African swine fever virus infection in vitro.Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication.Strategies for the treatment of dengue virus infections: a narrative account.Antiherpes evaluation of soybean isoflavonoids.
P2860
Q26823130-0E21CAEF-35F2-4470-8C8E-2EE996904A25Q27024953-DC1A4333-113C-4721-A2F5-3FD1DE9CF8A6Q33656417-5D07B7C4-9C7C-4A01-8F45-2BDBCFA5C49DQ33905046-ADB9D720-2169-406D-AF09-0B663B37AFCBQ33959989-3C3589F4-C107-4458-BB35-C2B9B59CEBF8Q35598450-BACE90C5-F309-4D2F-9D92-D27D3981EDADQ35620154-C9B47DF9-E601-47C5-A051-077B5CE1FFB2Q35635901-B04240AA-05AB-4FAF-8717-B98E0BB10EBAQ35826584-F2D1185A-3BEF-4D57-8C69-E68E186E0BADQ37247060-9AF1E7FC-3767-435B-9E48-6BD8F376236BQ37828538-D515023B-4BA7-4444-B0C6-9731D2FAD8E0Q38007145-770AC51E-5ACA-42C4-892D-675B87E64EE0Q38061425-06911755-9B63-46C7-AAC6-CDBE31BD8AEEQ38061427-33C0E304-6D53-4E82-97F4-7C18EFDA4B81Q38615950-A73DAE17-27EC-4F5D-A5BB-5CBEC5BFF098Q38678630-E9FDADD1-B1DD-44E0-B696-BD31B754DED3Q39068701-ADF93FF3-5647-4FBE-A93D-E7F506244B8BQ39091684-16190177-8A28-4333-8772-712423CC0392Q39379569-17FEF02C-D2A6-454C-A459-A41C39E6E37EQ39468140-12FBC7AE-B4AA-4F94-83C3-CCC2EBE83B63Q39611749-FCFF806F-60B7-4D5E-8A66-1CC2593E0976Q39769368-A5D5A2BE-298D-41A4-8C91-0044C205059BQ41117606-608A6A26-3869-4A54-9A42-18AFF8F955A2
P2860
Genistein treatment of cells inhibits arenavirus infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genistein treatment of cells inhibits arenavirus infection.
@en
type
label
Genistein treatment of cells inhibits arenavirus infection.
@en
prefLabel
Genistein treatment of cells inhibits arenavirus infection.
@en
P2093
P2860
P1433
P1476
Genistein treatment of cells inhibits arenavirus infection.
@en
P2093
Eric M Vela
Gavin C Bowick
Judith F Aronson
Norbert K Herzog
P2860
P304
P356
10.1016/J.ANTIVIRAL.2007.09.005
P577
2007-10-08T00:00:00Z